Back to CVE records
Medium 6.1Published Nov 6, 2025

CVE-2025-36054IBM Business Automation Workflow containers 24.0.0 through 24.0.0-IF006, 24.0.1 through 24.0.1-IF004, 25.0.0 through 25.0.0-IF001 and IBM Business Automation Workflow traditional with Process Federat…

Updated under an hour ago ()

Does this affect you?

It affects ibm business_automation_workflow and 1 other product. Add what you run to find out whether that includes you.

No exploitation reported and no EPSS estimate yet.

IBM Business Automation Workflow containers 24.0.0 through 24.0.0-IF006, 24.0.1 through 24.0.1-IF004, 25.0.0 through 25.0.0-IF001 and IBM Business Automation Workflow traditional with Process Federation Server 24.0.0 through 24.0.1 and 25.0.0 are vulnerable to cross-site scripting. This vulnerability allows an unauthenticated attacker to embed arbitrary JavaScript code in the Web UI thus altering the intended functionality potentially leading to credentials disclosure within a trusted session.

CVSS
6.1 MEDIUM (v3.1, NVD)CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:C/C:L/I:L/A:N
Weakness (CWE)
CWE-79
Known exploited
Not in CISA's KEV catalog
EPSS (exploitation in the next 30 days)
Not loaded for this CVE
Assigned by
Not given
NVD analysis
Analyzed
Record last updated
Oct 18, 2026
First seen by InfoSec Signals
Oct 9, 2026

Affected products

Affected products
ibm business_automation_workflow
ibm:business_automation_workflow
all versions; 24.0.0; 24.0.0; 24.0.0; 24.0.0; 24.0.0; 24.0.0; 24.0.0; and 6 more ranges
NVD
ibm process_federation_server
ibm:process_federation_server
24.0.0; 24.0.1; 25.0.0
NVD

References

  • patch, vendor-advisory

The CVE record is authoritative. Products marked “from the name” were identified from the CNA's free-text names, not a CPE, and are matched less certainly. This product uses the NVD API but is not endorsed or certified by the NVD.

Your cookie choices
We use essential cookies to run this site, and, only with your consent, an advertising cookie from Google to measure whether our ads lead to sign-ups and subscriptions. See our for details.